Julie Moreno
Colorado State UniversityFort Collins
330029 RESULTS
Colorado State UniversityFort Collins
PAPER Zhu W, Li X, Xie W, Luo F, Kaur D, Andersen JK, Jankovic J, Le W
PAPER Lee JK, Tran T, Tansey MG
PAPER Wang S, Lv X, Zhang K, Lin T, Liu X, Yuan J, Dai Y, Li N
PAPER Miller BR, Walker AG, Fowler SC, von Hörsten S, Riess O, Johnson MA, Rebec GV
PAPER Papadeas ST, Maragakis NJ
RESEARCH NEWS 2009-10-14 Research News Two years ago, iffy results from a massive Phase 3 trial led a Canadian drug company to scrap development of its anti-amyloid therapy for Alzheimer disease. Today, seniors can purchase the very same compound, rebranded as a “science-based na
CONFERENCE COVERAGE 2009-10-14 Conference Coverage Adapted from an original article by Jennifer Altman in the September-October issue of Alzheimer Actualités, a newsletter published in French by the Ipsen Foundation. The Alzforum editors acknowledge the Foundation’s generosity in makin
RESEARCH NEWS 2009-10-14 Research News Dimebon appears as one bright light in a field of less-than-stellar clinical trial results of late. But like many stars that suddenly explode into view, is the compound destined to become a black hole? While the drug appeared to stave off cl
PAPER Mancino AM, Hindo SS, Kochi A, Lim MH
PAPER Cerdà-Costa N, de la Arada I, Avilés FX, Arrondo JL, Villegas S
PAPER Reale M, Greig NH, Kamal MA
PAPER Patel NS, Mathura VS, Bachmeier C, Beaulieu-Abdelahad D, Laporte V, Weeks O, Mullan M, Paris D
PAPER Diarra A, Geetha T, Potter P, Babu JR
PAPER Tsang SW, Keene J, Hope T, Spence I, Francis PT, Wong PT, Chen CP, Lai MK
No filters selected